Infusive Technologies Overview
- Founded
- 2004
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Infusive Technologies General Information
Description
Developer of proprietary and patented multi-chamber, sequential, dose syringe technology. The company develops syringe technology developed under its product name "ChaSyr" which allows for the sequential administration of two separate intravenous (IV) medications with a single syringe, replacing multiple syringes with just one.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
- 620 South Main Street
- Bountiful, UT 84010
- United States
Infusive Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Infusive Technologies‘s full profile, request access.
Request a free trialInfusive Technologies Patents
Infusive Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2676248-A1 | Mixing syringe with and without flush | Abandoned | 23-Jan-2007 | 00000000000 | |
| CA-2665697-A1 | Multi-chamber, sequential dose dispensing syringe | Abandoned | 10-Oct-2006 | 00000000000 | |
| US-20060173439-A1 | Syringe drive system | Abandoned | 18-Jan-2005 | 0000000000 | 00 |
| EP-1841475-A1 | Syringe drive system | Withdrawn | 18-Jan-2005 | 0000000000 | 0 |
| EP-1841475-A4 | Syringe drive system | Withdrawn | 18-Jan-2005 | A61M5/1454 | 0 |
Infusive Technologies Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gale Thorne Jr. | President & Chief Operating Officer |